When an increase in GGT is twofold higher than the increase in ALP, what is assumed to be the source of elevated ALP?

When an increase in GGT is twofold higher than the increase in ALP, what is assumed to be the source of elevated ALP?

• A. Liver
• B. Bone
• C. Kidney
• D. Pancreas

Answer: (A)

When there is a twofold increase in gamma-glutamyl transferase (GGT) compared to alkaline phosphatase (ALP), it suggests that the source of the elevated ALP is likely from the liver rather than other sources such as bone or kidney. GGT is an enzyme that is primarily associated with the liver and is often used as a marker to indicate liver dysfunction or disease. When both GGT and ALP levels are elevated, determining the underlying cause of the ALP elevation is essential. If GGT increases significantly more than ALP, it typically signals that the ALP elevation is due to hepatic origin. This is because, in liver conditions such as cholestasis or biliary obstruction, GGT levels often rise along with ALP, but the differential increase in GGT serves as a strong indicator of liver-related pathology. In contrast, a rise in ALP without a corresponding increase in GGT might suggest a different origin, such as from bone. Elevated ALP can also occur in conditions of increased bone turnover or growth, where GGT levels would not reflect the same increase. Therefore, the assumption that the source of elevated ALP, when GGT is markedly higher, is derived from the liver is well

When there is a twofold increase in gamma-glutamyl transferase (GGT) compared to alkaline phosphatase (ALP), it suggests that the source of the elevated ALP is likely from the liver rather than other sources such as bone or kidney.

GGT is an enzyme that is primarily associated with the liver and is often used as a marker to indicate liver dysfunction or disease. When both GGT and ALP levels are elevated, determining the underlying cause of the ALP elevation is essential. If GGT increases significantly more than ALP, it typically signals that the ALP elevation is due to hepatic origin. This is because, in liver conditions such as cholestasis or biliary obstruction, GGT levels often rise along with ALP, but the differential increase in GGT serves as a strong indicator of liver-related pathology.

In contrast, a rise in ALP without a corresponding increase in GGT might suggest a different origin, such as from bone. Elevated ALP can also occur in conditions of increased bone turnover or growth, where GGT levels would not reflect the same increase.

Therefore, the assumption that the source of elevated ALP, when GGT is markedly higher, is derived from the liver is well